Scientists Block Protein That Slows Colon Cancer by 33%

Scientists in South Korea just made a breakthrough that could transform how we treat colorectal cancer, and it all comes down to one protein.

Researchers at Ulsan National Institute of Science and Technology found that blocking a protein called NSMF caused cancer cells to age permanently and stop dividing. In mice experiments, turning off this protein reduced intestinal tumors and extended survival by 33.5% compared to untreated mice.

Here's what makes this discovery so promising: unlike chemotherapy, which attacks both healthy and cancerous cells, blocking NSMF left normal intestinal cells completely undamaged. The treatment specifically targeted tumor cells while leaving everything else alone.

NSMF normally helps cancer cells cope with their rapid, chaotic division. When researchers removed it in lab experiments with human cancer cells and in specially bred mice, tumor growth slowed or stopped entirely as the cancer cells fell into what scientists call "irreversible cellular aging."

Dr. Kyeong Jin Shin, who led the study published in Nucleic Acids Research, explained that the approach forces cancer cells into permanent aging, effectively stopping tumor growth without harming normal tissues. His team used antibodies to block the protein in lab tests and bred mice without the NSMF gene to test the effects over 16 to 20 weeks.

The timing couldn't be more crucial. Colorectal cancer cases among Americans under 50 have roughly doubled since the mid-1990s, with subtle symptoms often dismissed or misdiagnosed. Actor James Van Der Beek, who died at 48 in February after dismissing early warning signs, brought renewed attention to this alarming trend.

The Bright Side

While more research is needed before human trials begin, this discovery opens a completely new pathway for treatment. The research team didn't completely eliminate cancer at this stage, and they haven't yet determined how to safely block NSMF in humans, but they've proven the concept works.

Professor Young Chan Chae noted this research reveals a previously unknown role for NSMF in colorectal cancer. Developing drugs that target this protein could offer patients a treatment that causes cancer cells to naturally age and die, potentially with fewer devastating side effects than current options.

For the millions facing this disease, especially younger adults seeing unexpected diagnoses, this research represents genuine hope for gentler, more effective treatments ahead.